Texas Children's Cancer Center

Both studies found that about 40 percent of pediatric cancer patients have mutations with potential clinical significance, either for diagnosis or treatment.

The new Pediatric Center for Personal Cancer Genomics and Therapeutics plans to routinely sequence every new patient that comes into the Texas Children's Cancer Center and hopes eventually to begin sequencing all new pediatric cancer cases in the state of Texas.

BCM has started a new pediatric cancer research center that will use clinical tumor sequencing for research and to develop treatments.

The Doris Duke Charitable Foundation has given a nearly $500,000 grant to the Texas Children's Cancer Center and Baylor to identify glioma-causing genetic mutations.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.